We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$599M
AUM Growth
+$99.2M
(+20%)
Cap. Flow
+$49.8M
Cap. Flow
% of AUM
8.31%
Top 10 Holdings %
Top 10 Hldgs %
34.81%
Holding
710
New
83
Increased
162
Reduced
252
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$19.1M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$14.1M |
| 3 |
iShares MSCI Turkey ETF
TUR
|
+$14M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$10.8M |
| 5 |
iShares MSCI Thailand ETF
THD
|
+$9.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$16.7M |
| 2 |
Rogers Communications
RCI
|
+$6.28M |
| 3 |
TechnipFMC
FTI
|
+$5.75M |
| 4 |
PepsiCo
PEP
|
+$4.71M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 9.52% |
| 2 | Financials | 9.27% |
| 3 | Communication Services | 8.11% |
| 4 | Technology | 7.63% |
| 5 | Materials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCE
276
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $175K | 0.03% |
2,098
| – | – |
|
277
Toronto Dominion Bank
TD
$198B
| $172K | 0.03% |
3,000
-34,000
| -92% | -$1.95M |
|
278
TC Energy
TRP
$73.5B
| $171K | 0.03% |
4,018
| – | – |
|
279
Invesco QQQ Trust
QQQ
$450B
| $168K | 0.03% |
978
| – | – |
|
|
ADAP
280
DELISTED
Adaptimmune Therapeutics
ADAP
| $160K | 0.03% |
13,372
| – | – |
|
281
Union Pacific
UNP
$183B
| $155K | 0.03% |
1,096
+504
| +85% | +$70.3K |
|
282
CSX Corp
CSX
$98.6B
| $152K | 0.03% |
7,158
-14,877
| -68% | -$306K |
|
283
Netflix
NFLX
$292B
| $152K | 0.03% |
3,850
-1,720
| -31% | -$58.6K |
|
284
ICICI Bank
IBN
$106B
| $151K | 0.03% |
18,815
-1,624
| -8% | -$13.9K |
|
285
SS&C Technologies
SSNC
$17.8B
| $148K | 0.02% |
2,855
-54
| -2% | -$2.73K |
|
|
CLR
286
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $147K | 0.02% |
2,274
| – | – |
|
287
ServiceNow
NOW
$102B
| $147K | 0.02% |
4,250
+25
| +0.6% | +$866 |
|
288
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.64B
| $145K | 0.02% |
2,740
| – | – |
|
289
ICU Medical
ICUI
$3.93B
| $143K | 0.02% |
487
| – | – |
|
290
Melco Resorts & Entertainment
MLCO
$2.1B
| $142K | 0.02% |
5,000
| – | – |
|
291
FMC
FMC
$1.42B
| $141K | 0.02% |
+1,809
| New | +$134K |
|
292
Biogen
BIIB
$29.9B
| $139K | 0.02% |
475
-1,560
| -77% | -$439K |
|
|
TVRD
293
Tvardi Therapeutics
TVRD
$23.5M
| $138K | 0.02% |
+200
| New | +$102K |
|
|
FOLD
294
DELISTED
Amicus Therapeutics
FOLD
| $137K | 0.02% |
+8,800
| New | +$133K |
|
295
AGNC Investment
AGNC
$12.3B
| $137K | 0.02% |
7,285
-1,087
| -13% | -$20.5K |
|
296
Bank of Montreal
BMO
$125B
| $136K | 0.02% |
1,775
-27,000
| -94% | -$2.08M |
|
297
American Airlines Group
AAL
$9.58B
| $136K | 0.02% |
3,536
+3,534
| +176,700% | +$156K |
|
298
Intel
INTC
$466B
| $136K | 0.02% |
2,724
-48,742
| -95% | -$2.59M |
|
299
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
| $135K | 0.02% |
1,800
| – | – |
|
|
K
300
DELISTED
Kellanova
K
| $135K | 0.02% |
2,067
-2,569
| -55% | -$153K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2018 Portfolio in Review
As of Q2 2018, Exane Derivatives held 710 positions worth $599M, up 20% from $500M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Exane Derivatives deployed $49.8M of net new capital in Q2 2018, opening 83 new positions and adding to 162 existing holdings. Its largest new stake was UBS Group: 1,172,516 shares worth $18.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $16.7M trimmed.
- Exane Derivatives's largest Q2 2018 buy was UBS Group: 1,172,516 shares worth $18.1M.
- Exane Derivatives added most to VanEck Russia ETF in Q2 2018, an estimated $14.1M increase.
- Exane Derivatives's biggest Q2 2018 reduction was Freeport-McMoran, cutting an estimated $16.7M.
- Exane Derivatives fully exited Rogers Communications in Q2 2018, selling an estimated $6.28M.
- Exane Derivatives's ten largest holdings make up 35% of its $599M portfolio in Q2 2018.
- Exane Derivatives opened 83 new positions and closed 24 in Q2 2018.
- Exane Derivatives's portfolio value rose 20% quarter-over-quarter to $599M.
Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.